Clinical Trials
2 trialsNCT07574541 2026-06-05
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
Phase 2 Not yet recruiting
NCT07618793 2026-06-01
Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma
Xuanwu Hospital, Beijing
Phase 2 Not yet recruiting